The dawn of digital pathology has ushered in a new era of diagnostic possibilities. Today, we stand at the cusp of a further revolution, driven by the synergistic power of Generative AI and agentic frameworks. Gen-AI promises to enrich our datasets with synthetic images, accelerate biomarker discovery, and refine reporting, while agentic AI aims to automate complex workflows, from ROI detection to case prioritization. However, this transformative potential comes with critical considerations. We must address data bias, ensure rigorous validation, and uphold ethical standards. This speech will explore the realistic applications of these technologies in digital pathology, highlighting both their immense promise and the crucial need for responsible implementation, ensuring that AI serves as a powerful tool to augment, not replace, the expertise of pathologists, ultimately enhancing patient care.